Shanghai INT Medical Instruments Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
280.00
231.00
193.00
167.00
187.00
154.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
7.00
-40.00
-27.00
34.00
-71.00
-34.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
379.00
252.00
206.00
224.00
105.00
134.00
Cash Flow from Investing Activities
-547.00
-212.00
-322.00
-378.00
-309.00
-267.00
Cash Flow from Financing Activities
293.00
63.00
8.00
7.00
-68.00
-40.00
Net Cash Inflow / Outflow
117.00
106.00
-104.00
-142.00
-276.00
-187.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-7.00
3.00
3.00
4.00
-3.00
-14.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shanghai INT Medical Instruments Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
280.790692343683
759.469000000249
-479.00
-63.03%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
7.49731006180551
-58.2440000000191
65.00
112.87%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
379.626560687748
738.012000000242
-359.00
-48.56%
Cash Flow from Investing Activities
-547.748289093799
-278.123000000091
-269.00
-96.94%
Cash Flow from Financing Activities
293.249696826544
-550.566000000181
843.00
153.26%
Net Cash Inflow / Outflow
117.944085612827
-49.7780000000163
166.00
336.94%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-7.18388280766667
40.8990000000134
-47.00
-117.56%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 50.19% vs 22.54% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
379.63
252.77
50.19%






